Clinical trial
Anticoagulation in the Management of Grade I-III Blunt Cerebrovascular Injuries
NCT00494156 is registered in ClinicalTrials.gov with C. Clay Cothren, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anticoagulation in the Management of Grade I-III Blunt Cerebrovascular Injuries
- Lead sponsor
- C. Clay Cothren, MD
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- July 31, 2003
- Completion date
- July 31, 2008
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carotid artery injury, vertebral artery injury